Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry
Evidence dashboardStudies since 2003Updated Jul 31, 2026

TriptorelinClinical Trials.

A source-linked view of every Triptorelin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
75
Recruiting
24
Completed
17
Terminated
1
Results posted
11
Average enrollment
495
Countries
63
Highest phase
Phase 4

Largest indexed study

4,170 participants · NCT04961996 →

Developer / research origin

Ipsen

Evidence summary

Activity is not efficacy.

Triptorelin appears in 75 indexed studies: 24 recruiting, 17 completed and 11 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Triptorelin is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

2003—2026

200320032008200820092012201220122014201520182019202020202020202120212021

Velocity

Triptorelin studies by start year

Study start year · indexed snapshot

151184020032003: 2 trials2004: 0 trials2005: 0 trials2006: 0 trials20072007: 0 trials2008: 2 trials2009: 2 trials2010: 0 trials20112011: 0 trials2012: 3 trials2013: 0 trials2014: 1 trials20152015: 2 trials2016: 0 trials2017: 2 trials2018: 3 trials20192019: 1 trials2020: 3 trials2021: 7 trials2022: 4 trials20232023: 10 trials2024: 7 trials2025: 11 trials20262026: 15 trials

Development

Trials by phase

Early Phase 13
Phase 12
Phase 231
Phase 330
Phase 44

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

Showing 6 of 53 studies
Showing 6 of 17 studies

Full study index

Search Triptorelin trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

75 matching studies

Latest publications

Follow the paper trail.

PMID 36710203 ↗Montgomery B, Mostaghel EA. Neoadjuvant Therapy Prior to Prostatectomy: Is the Glass Half Full? Eur Urol. 2023 Jun;83(6):519-520. doi: 10.1016/j.eururo.2023.01.021. Epub 2023 Jan 27. No abstract available.Linked from NCT05498272PMID 28601378 ↗Surrey ES, Katz-Jaffe M, Kondapalli LV, Gustofson RL, Schoolcraft WB. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression. Reprod Biomed Online. 2017 Aug;35(2):145-151. doi: 10.1016/j.rbmo.2017.05.004. Epub 2017 May 17.Linked from NCT07696351PMID 25331066 ↗Tamura H, Takasaki A, Nakamura Y, Numa F, Sugino N. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. J Ovarian Res. 2014 Oct 21;7:100. doi: 10.1186/s13048-014-0100-8.Linked from NCT07696351PMID 36375827 ↗Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022 Nov 14;379:e070750. doi: 10.1136/bmj-2022-070750.Linked from NCT07696351PMID 30927417 ↗Begueria R, Garcia D, Vassena R, Rodriguez A. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. Hum Reprod. 2019 May 1;34(5):872-880. doi: 10.1093/humrep/dez034.Linked from NCT06134479PMID 28368800 ↗Benchabane M, Santulli P, Maignien C, Bourdon M, De Ziegler D, Chapron C, Gayet V. [Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for oocyte donors]. Gynecol Obstet Fertil Senol. 2017 Feb;45(2):83-88. doi: 10.1016/j.gofs.2016.12.022. Epub 2017 Feb 16. French.Linked from NCT06134479PMID 24813196 ↗Blockeel C, Polyzos NP, Derksen L, De Brucker M, Vloeberghs V, van de Vijver A, De Vos M, Tournaye H. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study. Hum Reprod. 2014 Jul;29(7):1500-7. doi: 10.1093/humrep/deu105. Epub 2014 May 9.Linked from NCT06134479PMID 30929731 ↗Cozzolino M, Vitagliano A, Cecchino GN, Ambrosini G, Garcia-Velasco JA. Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2019 Apr;111(4):722-733. doi: 10.1016/j.fertnstert.2018.11.047.Linked from NCT06134479

Related pages

Keep researching Triptorelin.

Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.

DatabaseTriptorelin database page →Research guideRead the Triptorelin guide →Lab reportsSearch the COA ledger →Source registrySearch ClinicalTrials.gov ↗